StockData
BioAtla, Inc. logo

BioAtla, Inc. (BCAB) stock

BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$1.31−0.05 (-3.68%)

Close on Oct 19, 2026Market cap $2.18MP/E –Yield –

BioAtla revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

BioAtla's revenue for the twelve months ending Sep 30, 2022 was $0. For fiscal 2021 it was $300.00K.

Annual revenue

PeriodPeriod endValueChange
FY2021Dec 31, 2021$300.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2023Sep 30, 2023$0–
Q2 FY2023Jun 30, 2023$0–
Q1 FY2023Mar 31, 2023$0–
Q3 FY2022Sep 30, 2022$0–
Q2 FY2022Jun 30, 2022$0-100.0%
Q1 FY2022Mar 31, 2022$0–
Q4 FY2021Dec 31, 2021$0–
Q3 FY2021Sep 30, 2021$0–
Q2 FY2021Jun 30, 2021$300.00K–

More BioAtla figures

See a number that looks wrong?